Newsletters of the year 2000
- March 2000 - N° 1
Editorial
From the European Concerted Action for Cystic Fibrosis to .. A Cystic Fibrosis European Thematic Network - E. Dequeker
First steering committee meeting of the European CF Network - E. Dequeker
CF-Related diseases - C. Bombieri and P.F. Pignatti
Clinical Progress in CF, 1999 - 2000 - J. Dodge
What is on the clinical CF program for 2000? - J. Dodge
The European quality assessment scheme for CF 1999 - E. Dequeker
Ethical, legal and social impact of the use of new diagnostics and therapeutics - K. Dierickx, H. Nys
Informed consent and patent law - P. Saelen
Towards validation of CFTR gene expression and function assays - J. Lavinha
Announcements
Congresses and meetings - July 2000 - N° 2
Editorial
13th International Cystic Fibrosis congress - J. Dodge
Satellite symposium of the European CF Thematic Network - E. Dequeker
Activity report of the working group on CFTR expression - S. Beck
The European Cystic Fibrosis Society (ESCF) - G. Düring
European network for CF - Patients' point of view - K. De Rijcke
Report of the 1999 European Quality Assessment schemes for CF - E. Dequeker
The European CF twin and sibling study: current status - F. Mekus
Informed consent and patent law (continued) - P. Saelen
Cystic fibrosis in Finland - Resource centres, health care and rehabilitation - L. Jokinen
Announcements
Congresses and meetings - October 2000 - N° 3
Editorial
Ethical, legal and social impact of the use of new diagnostics and therapeutics - H. Nys
What is happening under the CF network for the diagnostic molecular genetic laboratories - E. Dequeker
Advances in the Activities of the Working Group on CFTR Expression - Resources - M. D. Amaral, S. Beck
A Short History of how the Informed Consent Recital came into the EU Biotechnology Directive - P. Saelen, G. Van Overwalle
Announcements
Congresses and meetings
Last changed: 2009-08-24
Contact
Home